Tech Company Financing Transactions

Evotec Funding Round

Private investors participated in a $2.9 million funding round for Evotec. The financing round was announced on 11/16/2026.

Transaction Overview

Company Name
Announced On
11/16/2026
Transaction Type
Venture Equity
Amount
$2,900,000
Round
Undisclosed
Investors
Proceeds Purpose
Evotec will use the $2.9 million grant from the Gates Foundation to continue developing and applying its human stem cell-based New Approach Methodologies (NAMs) for identifying potential fetal development safety risks associated with new drug candidates. The funding extends the project originally initiated in 2023 for an additional three years, providing global health researchers with continued access to Evotec's human induced pluripotent stem cell (hiPSC) platform and industrial-scale screening capabilities. The technology will help researchers assess potential developmental risks earlier in drug discovery, make better-informed decisions about which drug candidates should advance to clinical testing, and potentially reduce reliance on animal testing.

Company Information

Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Manfred Eigen Campus, Essener Bogen 7,
Hamburg, 22419
DE
Email Address
Overview
Evotec SE is a global life science and drug discovery company headquartered in Hamburg, Germany. It provides research and development services to pharmaceutical, biotechnology and academic organisations. Its integrated drug discovery and development platform supports customers from early-stage research and target identification through preclinical development and clinical-stage projects. The company also develops its own therapeutic programmes and collaborates with partners to advance treatments for various diseases.
Profile
Evotec LinkedIn Company Profile
Social Media
Evotec Company Twitter Account
Company News
Evotec News
Facebook
Evotec on Facebook
YouTube
Evotec on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Christian Wojczewski
  Christian Wojczewski LinkedIn Profile  Christian Wojczewski Twitter Account  Christian Wojczewski News  Christian Wojczewski on Facebook
Chief Financial Officer
Claire Hinshelwood
  Claire Hinshelwood LinkedIn Profile  Claire Hinshelwood Twitter Account  Claire Hinshelwood News  Claire Hinshelwood on Facebook
Chief Operating Officer
Ingrid Müller
  Ingrid Müller LinkedIn Profile  Ingrid Müller Twitter Account  Ingrid Müller News  Ingrid Müller on Facebook
Chief Scientific Officer
Joanna Holbrook
  Joanna Holbrook LinkedIn Profile  Joanna Holbrook Twitter Account  Joanna Holbrook News  Joanna Holbrook on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/16/2026: 201 Therapeutics venture capital transaction
Next: 11/16/2026: Daisytuner venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary